Current developments in the use of transcatheter aortic valve implantation in high-risk patients

References

• Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–1243.
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
   PubMed Web of Science ®Google Scholar
• Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38: 61–67.
   PubMed Web of Science ®Google Scholar
• Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2:533–539.
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106: 3006–3008.
   PubMed Web of Science ®Google Scholar
• Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv. 2005;66:465–469.
   Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. PARTNER trial: transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198.
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214–1223.
   PubMed Web of Science ®Google Scholar
• Kodali SK, O’Neill WW, Moses JW, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol. 2011;107:1058–1064.
   PubMed Web of Science ®Google Scholar
• Walther T, Kasimir MT, Doss M, et al. One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg. 2011;39: 532–537.
   PubMed Web of Science ®Google Scholar
• Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006;114:1616–1624.
   PubMed Web of Science ®Google Scholar
• Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842–850.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–1704.
   PubMed Web of Science ®Google Scholar
• Kodali SK, Williams MR, Smith CR. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–1695.
   PubMed Web of Science ®Google Scholar
• Hahn RT, Pibarot P, Stewart WJ, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (Placement of Aortic Transcatheter Valves). J Am Coll Cardiol. 2013;61:2514–2521.
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60:2683–2692.
   PubMed Web of Science ®Google Scholar
• Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention. 2012;8:383–389.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–1981.
   PubMed Web of Science ®Google Scholar
• Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–1798.
   PubMed Web of Science ®Google Scholar
• Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425–433.
   PubMed Web of Science ®Google Scholar
• Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–2138.
   PubMed Web of Science ®Google Scholar
• Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–1715.
   PubMed Web of Science ®Google Scholar
• Di Mario C, Eltchaninoff E, Moat N, et al. The 2011–2012 pilot European Sentinel Registry of transcatheter aortic valve implantation: in-hospital results in 4,571 patients. EuroIntervention. 2013;8: 1362–1371.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864–1875.
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Humphries KH, Lee M, et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61: 413–419.
   PubMed Web of Science ®Google Scholar
• Wood S. TAVI Registry Updates ADVANCE the field, raise hopes for lower stroke rates. Available from: http://www.medscape.com/viewarticle/760879. Accessed June 6, 2014.
   Google Scholar
• Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080–1090.
   PubMed Web of Science ®Google Scholar
• Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32:148–157.
   PubMed Web of Science ®Google Scholar
• Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62–69.
   PubMed Web of Science ®Google Scholar
• Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12:762–767.
   PubMed Web of Science ®Google Scholar
• Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32: 191–197.
   PubMed Web of Science ®Google Scholar
• Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54:303–311.
   PubMed Web of Science ®Google Scholar
• Walters DL, Sinhal A, Baron D, et al. Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year. Int J Cardiol. 2014;170:406–412.
   Web of Science ®Google Scholar
• Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310:2069–2077.
   PubMed Web of Science ®Google Scholar
• Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86:46–54.
   Web of Science ®Google Scholar
• D’Onofrio A, Rubino P, Fusari M, et al. Clinical and hemodynamic outcomes of “all-comers” undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA). J Thorac Cardiovasc Surg. 2011;142:768–775.
   PubMed Web of Science ®Google Scholar
• Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.
   PubMed Web of Science ®Google Scholar
• Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242–249.
   PubMedGoogle Scholar
• Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010;3:359–366.
   PubMed Web of Science ®Google Scholar
• Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299–308.
   PubMed Web of Science ®Google Scholar
• Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011;57:1650–1657.
   PubMed Web of Science ®Google Scholar
• Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198–204.
   PubMed Web of Science ®Google Scholar
• Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856–1864.
   PubMed Web of Science ®Google Scholar
• Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1–S44.
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/sts expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200–1254.
   PubMed Web of Science ®Google Scholar
• Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205–217.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Acdemic Research Consortium-2 consensus document. EuroIntervention. 2012;8:782–795.
   PubMed Web of Science ®Google Scholar
• Daneault B, Kirtane AJ, Kodali SK, et al. Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. J Am Coll Cardiol. 2011;58:2143–2150.
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129–138.
   PubMed Web of Science ®Google Scholar
• Ghanem A, Muller A, Nahle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427–1432.
   PubMed Web of Science ®Google Scholar
• Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870–878.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18–28.
   PubMed Web of Science ®Google Scholar
• Drews T, Pasic M, Buz S, et al. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg. 2011;59:237–242.
   PubMed Web of Science ®Google Scholar
• Szeto WY, Augoustides JG, Desai ND, et al. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg. 2011;26:348–354.
   Web of Science ®Google Scholar
• Miller DC, Blackstone EH, Mack MJ, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832–843. e13.
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Rodes-Cabau J, Urena M, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:178–188.
   PubMed Web of Science ®Google Scholar
• Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol. 2012;109:1637–1643.
   PubMed Web of Science ®Google Scholar
• Sponga S, Perron J, Dagenais F, et al. Impact of residual regurgitation after aortic valve replacement. Eur J Cardiothorac Surg. 2012;42:486–492.
   PubMed Web of Science ®Google Scholar
• Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–763.
   PubMed Web of Science ®Google Scholar
• Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007;116:I240–I245.
   PubMed Web of Science ®Google Scholar
• De Jaegere PP, Piazza N, Galema TW, et al. Early echocardiographic evaluation following percutaneous implantation with the selfexpanding CoreValve revalving system aortic valve bioprosthesis. EuroIntervention. 2008;4:351–357.
   Google Scholar
• Detaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv. 2009;2:821–827.
   PubMed Web of Science ®Google Scholar
• Buzzatti N, Maisano F, Latib A, et al. Computed tomography-based evaluation of aortic annulus, prosthesis size and impact on early residual aortic regurgitation after transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2013;43:43–50.
   Web of Science ®Google Scholar
• Schultz CJ, Tzikas A, Moelker A, et al. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis. Catheter Cardiovasc Interv. 2011;78:446–455.
   PubMed Web of Science ®Google Scholar
• Ewe SH, Ng AC, Schuijf JD, et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2011;108:1470–1477.
   PubMed Web of Science ®Google Scholar
• Haensig M, Lehmkuhl L, Rastan AJ, et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation. Eur J Cardiothorac Surg. 2012;41:1234–1240.
   PubMed Web of Science ®Google Scholar
• Block PC. Leaks and the “great ship” TAVI. Catheter Cardiovasc Interv. 2010;75:873–874.
   Web of Science ®Google Scholar
• Zoghbi W. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802.
   PubMed Web of Science ®Google Scholar
• Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585–1595.
   PubMed Web of Science ®Google Scholar
• Sutton JP 3rd, Ho SY, Anderson RH. The forgotten interleaflet triangles: a review of the surgical anatomy of the aortic valve. Ann Thorac Surg. 1995;59:419–427.
   PubMed Web of Science ®Google Scholar
• Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR. Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012;80:128–138.
   PubMed Web of Science ®Google Scholar
• Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1:310–316.
   PubMed Web of Science ®Google Scholar
• Fraccaro C, Buja G, Tarantini G, et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol. 2011;107:747–754.
   Google Scholar
• Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014;35(24):1599–1607.
   PubMed Web of Science ®Google Scholar
• Goldenberg G, Kusniec J, Kadmon E, et al. Pacemaker implantation after transcatheter aortic valve implantation. Am J Cardiol. 2013;112:1632–1634.
   Web of Science ®Google Scholar
• Genereux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60:1043–1052.
   PubMed Web of Science ®Google Scholar
• Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012;110:1361–1367.
   Google Scholar
• Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4:851–858.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Jilaihawi H, Chakravarty T, et al. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the US PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol. 2013;62:418–430.
   PubMed Web of Science ®Google Scholar
• Tuzcu EM. Transcatheter aortic valve replacement malposition and embolization: innovation brings solutions also new challenges. Catheter Cardiovasc Interv. 2008;72:579–580.
   PubMed Web of Science ®Google Scholar
• Naber CK, Ghanem A, Abizaid AA. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8:43–50.
   PubMed Web of Science ®Google Scholar
• Mullen M. First report of the DEFLECT trial: a prospective single arm feasibility study to evaluate the safety and performance of the Keystone Heart Trigard embolic deflection device in patients undergoing TAVI. Presented at the EuroPCR meeting, Paris, France, May 21–24, 2013.
   Google Scholar
• Rodes-Cabau J. Procedural and early neurological outcomes in the PROTAVI-C pilot study. Presented at the EuroPCR meeting, Paris, France, May 21–24, 2013.
   Google Scholar
• Grube E, Naber C, Abizaid A, Buellesfeld L. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv. 2011;4:751–757.
   PubMed Web of Science ®Google Scholar
• Noble S, Asgar A, Cartier R, Virmani R, Bonan R. Anatomo-pathological analysis after CoreValve Revalving system implantation. EuroIntervention. 2009;5:78–85.
   Web of Science ®Google Scholar
• Kini AS, Theodoropoulos K, Yu J, et al. Impact of Bivalirudin on access and non-access related bleeding in patients undergoing BAV (BRAVO). J Am Coll Cardiol. 2012;59:E266.
   Web of Science ®Google Scholar
• Van Belle E, Juthier F, Vincentelli A, et al. Can the use of a direct thrombin inhibitor prevent the risk of brain emboli during TAVI procedures? Eur Heart J. 2013;34 (Suppl 1).
   Google Scholar
• Jabbour A, Ismail TF, Moat N, et al. Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol. 2011;58:2165–2173.
   Web of Science ®Google Scholar
• Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol. 2012;59:1275–1286.
   PubMed Web of Science ®Google Scholar
• Willson AB, Webb JG, Labounty TM, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012;59:1287–1294.
   PubMed Web of Science ®Google Scholar
• Husser O, Rauch S, Endemann DH, et al. Impact of three-dimensional transesophageal echocardiography on prosthesis sizing for transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2012;80: 956–963.
   Web of Science ®Google Scholar
• Tamborini G, Fusini L, Gripari P, Muratori M, Pepi M. Feasibility and accuracy of 3D TEE versus CT for the evaluation of aortic valve annulus to the left main ostium distance before transcatheter aortic valve implantation. JACC Cardiovasc Imaging. 2012;5:579–588.
   PubMed Web of Science ®Google Scholar
• Sherif MA, Abdel-Wahab M, Stocker B, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Metronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010;56: 1623–1629.
   PubMed Web of Science ®Google Scholar
• Jilaihawi H, Chin D, Spyt T, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis. Eur Heart J. 2010;31:857–864.
   PubMed Web of Science ®Google Scholar
• Binder RK, Leipsic J, Wood D, et al. Prediction of optimal deployment projection for transcatheter aortic valve replacement: angiographic 3-dimensional reconstruction of the aortic root versus multidetector computed tomography. Circ Cardiovasc Interv. 2012;5:247–252.
   PubMed Web of Science ®Google Scholar
• Poon KK, Crowhurst J, James C, et al. Impact of optimising fluoroscopic implant angles on paravalvular regurgitation in transcatheter aortic valve replacements – utility of three-dimensional rotational angiography. EuroIntervention. 2012;8:538–545.
   Web of Science ®Google Scholar
• Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:1134–1141.
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Doss M, Schmermund A, Nowak B, Krissel J, Voigtlander T. Interventional options for severe aortic regurgitation after transcatheter aortic valve implantation: balloons, snares, valvein-valve. Clin Res Cardiol. 2012;101:503–507.
   Web of Science ®Google Scholar
• Nombela-Franco L, Rodes-Cabau J, DeLarochelliere R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5:499–512.
   PubMed Web of Science ®Google Scholar
• Vavuranakis M, Vrachatis DA, Toutouzas KP, Chrysohoou C, Stefanadis C. “Bail out” procedures for malpositioning of aortic valve prosthesis (CoreValve). Int J Cardiol. 2010;145:154–155.
   Web of Science ®Google Scholar
• Latib A, Michev I, Laborde JC, Montorfano M, Colombo A. Post-implantation repositioning of the CoreValve percutaneous aortic valve. JACC Cardiovasc Interv. 2010;3:119–121.
   PubMed Web of Science ®Google Scholar
• Piazza N, Schultz C, De Jaegere PT, Serruys PW. Implantation of two self-expanding aortic bioprosthesis valves during the same procedure? Insight into valve-in-valve implantation (“Russian doll” concept). Catheter Cardiovasc Interv. 2009;73:530–539.
   PubMed Web of Science ®Google Scholar
• Ussia GP, Barbanti M, Ramondo A, et al. The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis of incidence and 1-year clinical outcomes from the italian CoreValve registry. J Am Coll Cardiol. 2011;57:1062–1068.
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Wood DA, Rodes-Cabau J, et al. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc Interv. 2012;5:571–577.
   PubMed Web of Science ®Google Scholar
• Estevez-Loureiro R, Salgado-Fernandez J, Vazquez-Gonzalez N. Percutaneous closure of paravalvular leaks after transcatheter aortic valve implantation with Edwards SAPIEN prosthesis: a report of two cases. J Invasive Cardiol. 2013;25:92–95.
   Web of Science ®Google Scholar
• Poliacikova P, Hildick-Smith D. Paravalvular leak closure for persisting aortic regurgitation after implantation of the corevalve transcatheter valve. Catheter Cardiovasc Interv. October 15, 2013. [Epub ahead of print.]
   Web of Science ®Google Scholar
• Raffa GM, Malvindi PG, Settepani F, et al. Aortic valve replacement for paraprosthetic leak after transcatheter implantation. J Card Surg. 2012;27:47–51.
   PubMed Web of Science ®Google Scholar
• Ferreira ND, Caeiro D, Adao L, et al. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol. 2010;33:1364–1372.
   PubMed Web of Science ®Google Scholar
• Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23:391–397.
   PubMed Web of Science ®Google Scholar
• Mussardo M, Latib A, Chieffo A et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC Cardiovasc Interv. 2011;4:743–750.
   PubMed Web of Science ®Google Scholar
• Leon MB. A Randomized evaluation of the SAPIEN XT transcatheter valve system in patients with aortic stenosis who are not candidates for surgery: PARTNER II, inoperable cohort. American College of Cardiology Scientific Sessions San Francisco, CA 2013. Available from: http://www.cardiosource.org/~/media/Files/ScienceandQuality/ClinicalTrials/ACC13Slides/PARTNERIIPresentationSlides.ashx. Accessed June 6, 2014.
   Google Scholar
• Dimitriadis Z, Scholtz W, Faber L, et al. Balloon expandable sheath for transfemoral aortic valve implantation: a viable option for patients with challenging access. J Interv Cardiol. 2013;26: 84–89.
   Web of Science ®Google Scholar
• Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113–118.
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Leipsic J, Binder RK, et al. Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes. JACC Cardiovasc Interv. 2013;6:643–653.
   Web of Science ®Google Scholar
• Li X, Kong M, Jiang D, Dong A. Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg. 2013;8:168.
   PubMed Web of Science ®Google Scholar
• Petronio AS, De Carlo M, Bedogni F, et al. 2-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access. J Am Coll Cardiol. 2012;60:502–507.
   PubMed Web of Science ®Google Scholar
• D’Onofrio A, Rizzoli G, Messina A, et al. Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis. J Thorac Cardiovasc Surg. 2013;146:1065–1070.
   Google Scholar
• Tommaso CL, Bolman RM 3rd, Feldman T, et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2012;143:1254–1263.
   Web of Science ®Google Scholar
• Bourantas CV, Van Mieghem NM, Soliman O, Campos CA, Iqbal J, Serruys PW. Transcatheter aortic valve update 2013. EuroIntervention. 2013;9 Suppl:S84–S90.
   Google Scholar
• Gooley R, Antonis P, Meredith IT. The next era of transcatheter aortic valve replacement: a case illustrating the benefit of a fully re-positionable, re-sheathable and retrievable prosthesis. Catheter Cardiovasc Interv. 2014;83:831–835.
   PubMed Web of Science ®Google Scholar
• Binder RK, Rodes-Cabau J, Wood DA, Webb JG. Edwards SAPIEN 3 valve. EuroIntervention. 2012;8 Suppl Q:Q83–Q87.
   Web of Science ®Google Scholar
• Kempfert J, Mollmann H, Walther T. Symetis ACURATE TA valve. EuroIntervention. 2012;8 Suppl Q:Q102–Q109.
   Web of Science ®Google Scholar
• Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63:763–768.
   PubMed Web of Science ®Google Scholar
• Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013;61:1577–1584.
   PubMed Web of Science ®Google Scholar
• Seiffert M, Diemert P, Koschyk D, et al. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv. 2013;6:590–597.
   Web of Science ®Google Scholar
• Barbanti M, Ye J, Pasupati S, El-Gamel A, Webb JG. The Helio transcatheter aortic dock for patients with aortic regurgitation. EuroIntervention. 2013;9 Suppl:S91–S94.
   Google Scholar
• Gao G, Wu Y, Grunkemeier GL, Furnary AP, Starr A. Durability of pericardial versus porcine aortic valves. J Am Coll Cardiol. 2004;44:384–388.
   PubMed Web of Science ®Google Scholar
• Balsam LB, Grossi EA, Greenhouse DG, et al. Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann Thorac Surg. 2010;90:1195–1200.
   PubMed Web of Science ®Google Scholar
• Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126:2335–2344.
   PubMed Web of Science ®Google Scholar
• Gurvitch R, Cheung A, Ye J, et al. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol. 2011;58:2196–2209.
   PubMed Web of Science ®Google Scholar
• Webb JG, Dvir D. Transcatheter aortic valve replacement for bioprosthetic aortic valve failure: the valve-in-valve procedure. Circulation. 2013;127:2542–2550.
   PubMed Web of Science ®Google Scholar
• Cheung AW, Gurvitch R, Ye J, et al. Transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis: a case series. J Thorac Cardiovasc Surg. 2011;141:711–715.
   Web of Science ®Google Scholar
• Wilbring M, Alexiou K, Tugtekin SM, et al. Pushing the limits-further evolutions of transcatheter valve procedures in the mitral position, including valve-in-valve, valve-in-ring, and valve-in-native-ring. J Thorac Cardiovasc Surg. 2014;147:210–219.
   Web of Science ®Google Scholar
• Calvert PA, Himbert D, Brochet E, et al. Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks. EuroIntervention. 2012;7:1336–1339.
   Web of Science ®Google Scholar
• Mazzitelli D, Bleiziffer S, Noebauer C, et al. Transatrial antegrade approach for double mitral and tricuspid “valve-in-ring” implantation. Ann Thorac Surg. 2013;95:e25–e27.
   PubMed Web of Science ®Google Scholar
• Himbert D, Pontnau F, Messika-Zeitoun D, et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol. 2012;110:877–883.
   PubMed Web of Science ®Google Scholar
• Généreux P, Head SJ, Wood DA, et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J. 2012;33(19):2388–2398.
   Web of Science ®Google Scholar